Cleared Abbreviated

K152020 - Bindex BI-100 (FDA 510(k) Clearance)

May 2016
Decision
297d
Days
Class 2
Risk

K152020 is an FDA 510(k) clearance for the Bindex BI-100. This device is classified as a Bone Sonometer (Class II - Special Controls, product code MUA).

Submitted by Bone Index Finland , Ltd. (Kuopio, FI). The FDA issued a Cleared decision on May 13, 2016, 297 days after receiving the submission on July 21, 2015.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.1180. A Bone Sonometer Is A Device That Transmits Ultrasound Energy Into The Human Body To Measure Acoustic Properties Of Bone That Indicate Overall Bone Health And Fracture Risk. The Primary Components Of The Device Are A Voltage Generator, A Transmitting Transducer, A Receiving Transducer, And Hardware And Software For Reception And Processing Of The Received Ultrasonic Signal. Reclassified From Class 3 Pma To Class 2 510(k) 892.1180 [docket No. Fda-2005-n-0346] Reclassification Of Bone Sonometers.

Submission Details

510(k) Number K152020 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 21, 2015
Decision Date May 13, 2016
Days to Decision 297 days
Submission Type Abbreviated
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code MUA - Bone Sonometer
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.1180
Definition A Bone Sonometer Is A Device That Transmits Ultrasound Energy Into The Human Body To Measure Acoustic Properties Of Bone That Indicate Overall Bone Health And Fracture Risk. The Primary Components Of The Device Are A Voltage Generator, A Transmitting Transducer, A Receiving Transducer, And Hardware And Software For Reception And Processing Of The Received Ultrasonic Signal. Reclassified From Class 3 Pma To Class 2 510(k) 892.1180 [docket No. Fda-2005-n-0346] Reclassification Of Bone Sonometers